Loading...
Loading...
Toggle sidebar
Search Ctrl + K
Filing information
Talaris Therapeutics, Inc.
Filing: 10-K
Filed On: 2024-03-19
Email Link to Filing
Print Filing
Download PDF
Download all tables
Your filing highlights
Compare documents
EDGAR Index Page
Documents
10-K
10-K
EX-4.1
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
EX-4.2
Indenture
EX-21.1
Subsidiaries of the registrant
EX-23.1
Consents of experts and counsel
EX-31.1
Management Certification of annual or quarter disclosure
EX-31.2
Management Certification of annual or quarter disclosure
EX-32.1
Section 1350 Certifications
EX-97
a12312023exhibit97.htm
GRAPHIC
a12312023exhibit41001.jpg
GRAPHIC
a12312023exhibit41002.jpg
GRAPHIC
trml-20231231_g1.jpg
GRAPHIC
trml-20231231_g10.jpg
GRAPHIC
trml-20231231_g11.jpg
GRAPHIC
trml-20231231_g12.jpg
GRAPHIC
trml-20231231_g2.jpg
GRAPHIC
trml-20231231_g3.jpg
GRAPHIC
trml-20231231_g4.jpg
GRAPHIC
trml-20231231_g5.jpg
GRAPHIC
trml-20231231_g6.jpg
GRAPHIC
trml-20231231_g7.jpg
GRAPHIC
trml-20231231_g8.jpg
GRAPHIC
trml-20231231_g9.jpg
0001827506-24-000015.txt
Data files
EX-101.SCH
trml-20231231.xsd
EX-101.CAL
trml-20231231_cal.xml
EX-101.DEF
trml-20231231_def.xml
EX-101.LAB
trml-20231231_lab.xml
EX-101.PRE
trml-20231231_pre.xml
XML
trml-20231231_htm.xml
Free Trial
Save highlight
Link to highlight
Your browser does not support iframes.